Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|May 29, 2024

Overcoming Barriers to Better Patient Outcomes in PAH

Author(s)Ronald Oudiz, MD, FACP, FACC, FCCP

Ronald Oudiz, MD, FACP, FACC, FCCP, discusses the challenges and limitations associated with the adoption of new treatments and the impact of emerging therapies on patient outcomes, quality of life, and disease management in the long term.

Episodes in this series

Ronald Oudiz, MD, FACP, FACC, FCCP, an expert on pulmonary arterial hypertension

EP. 1 Evolving Guidelines for PAH Treatment

Ronald Oudiz, MD, FACP, FACC, FCCP, an expert on pulmonary arterial hypertension

EP. 2 New Therapeutic Frontiers in PAH

Ioana Preston, MD, a pulmonologist

EP. 3 Addressing Unmet Needs and Disease Progression Challenges in Pulmonary Arterial Hypertension Management

Ioana Preston, MD, a pulmonologist

EP. 4 Overcoming Limitations and Barriers Associated with Treating Pulmonary Arterial Hypertension

Marius Hoeper, MD, an expert on PAH

EP. 5 Breaking Down the PAH Cost Burden

Marius Hoeper, MD, an expert on PAH

EP. 6 A New Era in PAH Treatment?

"Clinical Evidence for Emerging PAH Therapies"

EP. 7 Clinical Evidence for Emerging PAH Therapies

"Integrating New PAH Therapies into Clinical Practice"

EP. 8 Integrating New PAH Therapies into Clinical Practice

Ioana Preston, MD, a pulmonologist

EP. 9 Optimizing Complex Pulmonary Arterial Hypertension Care: Enhancing Adherence and Outcomes

Marius Hoeper, MD, an expert on PAH

EP. 10 FDA Approves Sotatercept for Pulmonary Arterial Hypertension

Ronald Oudiz, MD, FACP, FACC, FCCP, an expert on pulmonary arterial hypertension

EP. 11 Overcoming Barriers to Better Patient Outcomes in PAH

Ioana Preston, MD, a pulmonologist

EP. 12 Advancing Pulmonary Arterial Hypertension Care: Overcoming Challenges in Special Populations and Exploring Innovative Approaches

Marius Hoeper, MD, an expert on PAH

EP. 13 Optimizing PAH Care Delivery for Better Outcomes

Marius Hoeper, MD, an expert on PAH

EP. 14 Addressing Unmet Needs in the PAH Landscape

Video content above is prompted by the following questions:

What are the potential challenges or limitations associated with the adoption of new treatments, such as cost, access, or safety concerns?
How might the evolving treatment landscape for PAH impact patient outcomes, quality of life, and disease management in the long term?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

2 experts in this video

Near-Term Priorities for Transforming Clinical Practice in IgA Nephropathy

ByEdward Skolnik, MD ,Swati Arora, MD

March 6th 2026

2 experts in this video

Rethinking KDIGO Guidance and Payer Models in the Era of Targeted IgA Nephropathy Therapies

ByEdward Skolnik, MD ,Swati Arora, MD

March 6th 2026

Contributor: Personalized Heart Risk and How AI-Powered Plaque Analysis Is Changing Prevention

ByChristopher D. Maroules, MD

March 2nd 2026

2 experts in this video

In Advocacy Strategies and the Expanding Role of Novel Therapies in IgA Nephropathy

ByEdward Skolnik, MD ,Swati Arora, MD

February 27th 2026

2 experts in this video

Overcoming Access Barriers and Step-Edit Challenges in IgA Nephropathy

ByEdward Skolnik, MD ,Swati Arora, MD

February 27th 2026

Trending on AJMC

How Often Do Health Insurers Deny Doctor-Recommended Care?

Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention

Acoramidis Shows Durable Benefit at 54 Months in ATTR-CM

Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes